Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells.

Koli KM, Ramsey TT, Ko Y, Dugger TC, Brattain MG, Arteaga CL
J Biol Chem. 1997 272 (13): 8296-302

PMID: 9079651 · DOI:10.1074/jbc.272.13.8296

MeSH Terms (14)

Breast Neoplasms Cyclin-Dependent Kinase Inhibitor p21 Cyclins Enzyme Inhibitors Estrogen Antagonists Female Humans Protein Serine-Threonine Kinases Receptor, Transforming Growth Factor-beta Type II Receptors, Transforming Growth Factor beta Tamoxifen Transforming Growth Factor beta Tumor Cells, Cultured Up-Regulation

Connections (1)

This publication is referenced by other Labnodes entities: